← Back to directory
B
Boehringer Ingelheim Venture Fund
🇬🇧 UK-activeSeed VC·Ingelheim, Germany·Partner: Martin Heidecker (Managing Director)
stages Seed, Series A; cheque €1M - €15M.
Cheque range (GBP)
£1.0M – £15M
Typical: €1M - €15M
Last cheque
4mo ago
● actively deploying
Rounds (12mo)
1
none in last 90d
Tracked portfolio
1
since 2026
Recent investments
1 tracked rounds via funding databases| Company | Amount | When |
|---|---|---|
| Brainomix ↗ Develops AI-powered imaging tools for stroke and lung fibrosis | $6.8M | 4mo ago |
Stages backed
Series C+1 · 100%
Markets backed
Sectors & focus
AI / MLB2B SaaSHealthtechBiotech / Life SciencesEdtechAIMachine LearningSaaSEnterpriseMedTechBiotech
Business models
SaaS, AI / ML, Deep tech
Frequent co-investors
From tracked deal dataWant a match-quality estimate?
Score your pitch and we'll tell you if Boehringer Ingelheim Venture Fund matches your stage, sector, and cheque — before you ever email them.
Score my pitch →For the team at Boehringer Ingelheim Venture Fund
This profile isn't claimed yet.
Claim it to correct your mandate, fix anything that's wrong, and start receiving UK founders who actually fit what you back.
Claim this profile →